Near-miss Osteomyelitis in an Immunosuppressed Crohn’s Disease Patient: Diagnostic Vigilance Sparked by a Medical Student

Downloads

Authors

DOI:

https://doi.org/10.71079/ASIDE.HS.092525225

Abstract

Crohn's disease (CD) patients on immunosuppressive therapy are at increased risk of infections, including osteomyelitis, which could be diagnostically challenging. This case highlights the importance of medical student vigilance in making a near-miss diagnosis of osteomyelitis in a CD patient.

A 56-year-old CD patient developed left shoulder pain following localized muscle injection and was initially managed as a soft-tissue abscess. The condition worsened despite 21 days of antibiotics. Investigation: Cultures were positive for methicillin-sensitive Staphylococcus aureus (MSSA). Persistent pain and new neurologic complaints prompted an MRI (T1 hypointensity, T2-STIR hyperintensity, post-contrast enhancement) at 60 days, in support of osteomyelitis without bone biopsy. Management/Outcome: The patient received 6 weeks of intravenous vancomycin (1 g every 12 hours), followed by oral antibiotics, resulting in partial relief of pain (pain score: 8/10 to 4/10) and improvement in shoulder function (Constant-Murley score: 30 to 65 at 3 months). Immunotherapy (adalimumab) was restarted after infection control.

This case highlights three practical lessons: maintaining a low threshold for advanced imaging in immunosuppressed patients with persistent pain; incorporating diagnostic time-outs to invite trainee perspectives; and seeking early infectious-disease consultation when osteomyelitis is suspected.

Keywords:

Crohn Disease, Osteomyelitis, Staphylococcus aureus, Diagnostic Errors, Medical Education

References

1. Bourikas LA, Papadakis KA. Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2009: 1915 [PMID: 19408334, https://doi.org/10.1002/ibd.20942] DOI: https://doi.org/10.1002/ibd.20942

2. Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000: 210 [PMID: 10967509, https://doi.org/10.1016/s0953-6205(00)00093-5] DOI: https://doi.org/10.1016/S0953-6205(00)00093-5

3. Sheth T, Pitchumoni CS, Das KM. Management of Musculoskeletal Manifestations in Inflammatory Bowel Disease. Gastroenterol Res Pract. 2015: 387891 [PMID: 26170832, https://doi.org/10.1155/2015/387891] DOI: https://doi.org/10.1155/2015/387891

4. Sheth T, Pitchumoni CS, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol. 2014: 308 [PMID: 24492406, https://doi.org/10.1097/MCG.0000000000000067] DOI: https://doi.org/10.1097/MCG.0000000000000067

5. Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021: 1118 [PMID: 34358489, https://doi.org/10.1053/j.gastro.2021.07.042] DOI: https://doi.org/10.1053/j.gastro.2021.07.042

6. Hountondji L, Rudler F, Blanc P. An Atypical Cause of Musculoskeletal Pain in a Patient With Chronic Inflammatory Bowel Disease. Gastroenterology. 2022: e8 [PMID: 35777475, https://doi.org/10.1053/j.gastro.2022.06.065] DOI: https://doi.org/10.1053/j.gastro.2022.06.065

7. Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician. 2011: 1027 [PMID: 22046943,

8. Lee YJ, Sadigh S, Mankad K, Kapse N, Rajeswaran G. The imaging of osteomyelitis. Quant Imaging Med Surg. 2016: 184 [PMID: 27190771, https://doi.org/10.21037/qims.2016.04.01] DOI: https://doi.org/10.21037/qims.2016.04.01

9. Lew DP, Waldvogel FA. Osteomyelitis. N Engl J Med. 1997: 999 [PMID: 9077380, https://doi.org/10.1056/NEJM199704033361406] DOI: https://doi.org/10.1056/NEJM199704033361406

10. Besal R, Adamic P, Beovic B, Papst L. Systemic Antimicrobial Treatment of Chronic Osteomyelitis in Adults: A Narrative Review. Antibiotics (Basel). 2023: [PMID: 37370263, https://doi.org/10.3390/antibiotics12060944] DOI: https://doi.org/10.3390/antibiotics12060944

11. Uchealth. Osteomyelitis: Diagnosis & treatment [Internet]. 2025.

12. Schmitt SK. Osteomyelitis. Infect Dis Clin North Am. 2017: 325 [PMID: 28483044, https://doi.org/10.1016/j.idc.2017.01.010] DOI: https://doi.org/10.1016/j.idc.2017.01.010

13. Urish KL, Cassat JE. Staphylococcus aureus Osteomyelitis: Bone, Bugs, and Surgery. Infect Immun. 2020: [PMID: 32094258, https://doi.org/10.1128/IAI.00932-19] DOI: https://doi.org/10.1128/IAI.00932-19

14. Nasser A, Azimi T, Ostadmohammadi S, Ostadmohammadi S. A comprehensive review of bacterial osteomyelitis with emphasis on Staphylococcus aureus. Microb Pathog. 2020: 104431 [PMID: 32801004, https://doi.org/10.1016/j.micpath.2020.104431] DOI: https://doi.org/10.1016/j.micpath.2020.104431

15. Wu S, Wu B, Liu Y, Deng S, Lei L, Zhang H. Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections. Front Microbiol. 2022: 936285 [PMID: 35774451, https://doi.org/10.3389/fmicb.2022.936285] DOI: https://doi.org/10.3389/fmicb.2022.936285

16. Mouton W, Josse J, Jacqueline C, Abad L, Trouillet-Assant S, Caillon J, Bouvard D, Bouchet M, Laurent F, Diot A. Staphylococcus aureus internalization impairs osteoblastic activity and early differentiation process. Sci Rep. 2021: 17685 [PMID: 34480054, https://doi.org/10.1038/s41598-021-97246-y] DOI: https://doi.org/10.1038/s41598-021-97246-y

17. Catalan-Serra I, Brenna O. Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Hum Vaccin Immunother. 2018: 2597 [PMID: 29624476, https://doi.org/10.1080/21645515.2018.1461297] DOI: https://doi.org/10.1080/21645515.2018.1461297

18. Irving PM, de Lusignan S, Tang D, Nijher M, Barrett K. Risk of common infections in people with inflammatory bowel disease in primary care: a population-based cohort study. BMJ Open Gastroenterol. 2021: [PMID: 33597152, https://doi.org/10.1136/bmjgast-2020-000573] DOI: https://doi.org/10.1136/bmjgast-2020-000573

19. Lichtenstein GR, Panaccione R, Mallarkey G. Efficacy and safety of adalimumab in Crohn's disease. Therap Adv Gastroenterol. 2008: 43 [PMID: 21180513, https://doi.org/10.1177/1756283X08092548] DOI: https://doi.org/10.1177/1756283X08092548

20. Johnston SL. Clinical immunology review series: an approach to the patient with recurrent superficial abscesses. Clin Exp Immunol. 2008: 397 [PMID: 18422735, https://doi.org/10.1111/j.1365-2249.2008.03640.x] DOI: https://doi.org/10.1111/j.1365-2249.2008.03640.x

21. Hamdar H, Petrova A, Paunov L, Murdjeva M. Microbiological Aspects of Joint and Bone Infections. ACTA MICROBIOLOGICA BULGARICA. 45

22. Marcum JA. The Bloomsbury companion to contemporary philosophy of medicine2016: https://doi.org/10.5040/9781474233033] DOI: https://doi.org/10.5040/9781474233033

23. Norman GR, Monteiro SD, Sherbino J, Ilgen JS, Schmidt HG, Mamede S. The Causes of Errors in Clinical Reasoning: Cognitive Biases, Knowledge Deficits, and Dual Process Thinking. Acad Med. 2017: 23 [PMID: 27782919, https://doi.org/10.1097/ACM.0000000000001421] DOI: https://doi.org/10.1097/ACM.0000000000001421

Data Availability Statement

 Patient data related to this study are not publicly available but can be obtained upon request from the corresponding author. 

Downloads

Share this article

Published

2025-09-25

Issue

Section

Case Report

How to Cite

1.
Al Bazzal A, Kawssan A, Akoum A, Kamar DM, Mtairek MA, Hamdar H. Near-miss Osteomyelitis in an Immunosuppressed Crohn’s Disease Patient: Diagnostic Vigilance Sparked by a Medical Student. ASIDE Health Sci. 2025;1(1):33-37. doi:10.71079/ASIDE.HS.092525225

Article history

Received
17 Aug 2025
Received in revised form
16 Sep 2025
Accepted
23 Sep 2025
Published
25 Sep 2025